Christina Liak1, M Fitzpatrick. 1. Division of Respirology & Critical Care Medicine, Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Abstract
BACKGROUND: Obstructive sleep apnea (OSA) is a common disorder that affects both quality of life and cardiovascular health. The causal link between OSA and cardiovascular morbidity⁄mortality remains elusive. One possible explanation is that repeated episodes of nocturnal hypoxia lead to a hypercoagulable state that predisposes patients to thrombotic events. There is evidence supporting a wide array of hematological changes that affect hemostasis (eg, increased hematocrit, blood viscosity, platelet activation, clotting factors and decreased fibrinolytic activity). OBJECTIVE: To provide a comprehensive review of the current evidence associating OSA with increased coagulability, and to highlight areas for future research. METHODS: Keyword searches in Ovid Medline were used to identify relevant articles; all references in the articles were searched for relevant titles. The Web of Science was used to identify articles citing the relevant articles found using the Ovid Medline search. All original peer-reviewed articles, meta-analyses and systematic reviews regarding the pertinent topics between 1990 and present were selected for review. RESULTS: Hematocrit, blood viscosity, certain clotting factors, tissue factor, platelet activity and whole blood coagulability are increased in patients with OSA, while fibrinolysis is impaired. CONCLUSION: There is considerable evidence that OSA is associated with a procoagulant state. Several factors are involved in the procoagulant state associated with OSA. There is a need for adequately powered clinical studies involving well-matched control groups to address potential confounding variables, and to accurately delineate the individual factors involved in the procoagulant state associated with OSA and their response to treatment.
BACKGROUND: Obstructive sleep apnea (OSA) is a common disorder that affects both quality of life and cardiovascular health. The causal link between OSA and cardiovascular morbidity⁄mortality remains elusive. One possible explanation is that repeated episodes of nocturnal hypoxia lead to a hypercoagulable state that predisposes patients to thrombotic events. There is evidence supporting a wide array of hematological changes that affect hemostasis (eg, increased hematocrit, blood viscosity, platelet activation, clotting factors and decreased fibrinolytic activity). OBJECTIVE: To provide a comprehensive review of the current evidence associating OSA with increased coagulability, and to highlight areas for future research. METHODS: Keyword searches in Ovid Medline were used to identify relevant articles; all references in the articles were searched for relevant titles. The Web of Science was used to identify articles citing the relevant articles found using the Ovid Medline search. All original peer-reviewed articles, meta-analyses and systematic reviews regarding the pertinent topics between 1990 and present were selected for review. RESULTS: Hematocrit, blood viscosity, certain clotting factors, tissue factor, platelet activity and whole blood coagulability are increased in patients with OSA, while fibrinolysis is impaired. CONCLUSION: There is considerable evidence that OSA is associated with a procoagulant state. Several factors are involved in the procoagulant state associated with OSA. There is a need for adequately powered clinical studies involving well-matched control groups to address potential confounding variables, and to accurately delineate the individual factors involved in the procoagulant state associated with OSA and their response to treatment.
Authors: Heidi Grundt; Dennis Winston T Nilsen; Øyvind Hetland; Edward Valente; Hans Eirik Fagertun Journal: Am Heart J Date: 2004-02 Impact factor: 4.749
Authors: Jong Bae Choi; José S Loredo; Daniel Norman; Paul J Mills; Sonia Ancoli-Israel; Michael G Ziegler; Joel E Dimsdale Journal: Sleep Breath Date: 2006-09 Impact factor: 2.816
Authors: Rainier Dziewas; Marius Humpert; Benjamin Hopmann; Stephan P Kloska; Peter Lüdemann; Martin Ritter; Ralf Dittrich; E Bernd Ringelstein; Peter Young; Darius G Nabavi Journal: J Neurol Date: 2005-07-20 Impact factor: 4.849
Authors: A M Thögersen; J H Jansson; K Boman; T K Nilsson; L Weinehall; F Huhtasaari; G Hallmans Journal: Circulation Date: 1998-11-24 Impact factor: 29.690
Authors: Dinah Konnerth; Florian Schwarz; Michael Probst; Martin Seidler; Tanja Wagner; Christian Faul; Wolfgang von Scheidt; Martin Schwaiblmair; Thomas M Berghaus Journal: J Thromb Thrombolysis Date: 2018-08 Impact factor: 2.300
Authors: Mako Nagayoshi; Pamela L Lutsey; David Benkeser; Christina L Wassel; Aaron R Folsom; Eyal Shahar; Hiroyasu Iso; Matthew A Allison; Michael H Criqui; Susan Redline Journal: Atherosclerosis Date: 2016-06-25 Impact factor: 5.162